維拉治療公司
US ˙ NasdaqGM ˙ US92337R1014

SecurityVERA / Vera Therapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership89,163 shares
Latest Disclosed Value $ 2,100,680
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 16.94% increase in ownership of VERA / Vera Therapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 89,163 shares of Vera Therapeutics, Inc. (US:VERA) valued at $2,100,680 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 76,247 shares of Vera Therapeutics, Inc.. This represents a change in shares of 16.94% during the quarter. The current value of the position is $2,879,073 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Vera Therapeutics EC US92337R1014 89,163 12,916 16.94 2,101 14.69 0.0472
2025-05-28 2025-03-31 NP Vera Therapeutics EC US92337R1014 76,247 1,478 1.98 1,831 -42.08 0.0439
2025-02-25 2024-12-31 NP Vera Therapeutics EC US92337R1014 74,769 -2,419 -3.13 3,162 -7.33 0.0690
2024-11-26 2024-09-30 NP Vera Therapeutics EC US92337R1014 77,188 1,285 1.69 3,412 24.22 0.0645
2024-08-26 2024-06-30 NP Vera Therapeutics EC US92337R1014 75,903 5,613 7.99 2,746 -9.37 0.0559
2024-05-28 2024-03-31 NP Vera Therapeutics EC US92337R1014 70,290 7,111 11.26 3,031 212.05 0.0632
2024-02-26 2023-12-31 NP Vera Therapeutics EC US92337R1014 63,179 6,874 12.21 972 25.94 0.0207
2023-11-28 2023-09-30 NP Vera Therapeutics EC US92337R1014 56,305 -2,474 -4.21 772 -18.24 0.0201
2023-08-25 2023-06-30 NP Vera Therapeutics EC US92337R1014 58,779 25,123 74.65 943 261.30 0.0224
2023-05-26 2023-03-31 NP Vera Therapeutics EC US92337R1014 33,656 10,402 44.73 261 -41.87 0.0070
2023-02-24 2022-12-31 NP Vera Therapeutics EC US92337R1014 23,254 -2,607 -10.08 450 -18.51 0.0124
2022-11-25 2022-09-30 NP Vera Therapeutics EC US92337R1014 25,861 0 0.00 551 56.98 0.0158
2022-08-25 2022-06-30 NP Vera Therapeutics EC US92337R1014 25,861 5,755 28.62 352 -25.64 0.0097
2022-05-26 2022-03-31 NP Vera Therapeutics EC US92337R1014 20,106 5,012 33.21 472 17.12 0.0110
2022-02-25 2021-12-31 NP Vera Therapeutics EC US92337R1014 15,094 15,094 403 0.0087
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.